VTGN earnings

Vistagen Therapeutics (VTGN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

VTGN earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q2 2027Nov 13, 2026-0.24––$138.00K
Q1 2027Aug 14, 2026-0.30––$1.48M
Q4 2026Jun 15, 2026-0.37-0.4211.90%$464.00K
Q3 2026Feb 12, 2026-0.45-0.5111.76%$303.00K
Q2 2026Nov 13, 2025-0.54-0.51-5.88%$258.00K
Q1 2026Aug 7, 2025-0.47-0.470.00%$244.00K
Q4 2025Jun 17, 2025-0.43––-$15.00K
Q3 2025Feb 13, 2025-0.46-0.484.17%$234.00K
Q2 2025Nov 7, 2024-0.42-0.40-5.00%$183.00K
Q1 2025Aug 13, 2024-0.35––$84.00K
Q4 2024Jun 11, 2024-0.25-0.3426.47%$198.00K
Q3 2024Feb 13, 2024-0.22––$411.00K
Q2 2024Nov 9, 2023-0.66-0.682.94%$278.00K
Q1 2024Aug 10, 2023-0.94-0.86-9.30%$177.00K
Q3 2023Feb 7, 2023-1.50-1.8016.67%$179.60K
Q2 2023Nov 10, 2022-2.40––-$892.50K